Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Essiac Canada International is a healthcare company focused on the production and global distribution of the Essiac herbal formula. Originally developed by Canadian nurse Rene Caisse in the 1920s, the formula is a proprietary blend of four main herbs: burdock root, sheep sorrel, slippery elm, and Indian rhubarb. The company acquired the rights to the original formula from the Resperin Corporation, which had received it directly from Caisse. Currently, Essiac is marketed as a dietary supplement intended for immune support and detoxification, though it remains a prominent name in alternative oncology. The company operates primarily through its headquarters in Canada and distribution networks in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Essiac Products.